Anti-RSV F Glycoprotein [11-3-A3]

Human Respiratory Syncytial Virus (RSV) is a major cause of lower respiratory tract illness and is the chief cause of hospitalization for respiratory tract illness in young children.The glycoprotein F is located on the surface of viral envelope, its function is to induce fusion of viral envelope with host-cell envelope resulting in syncytium formation. The glycoprotein F (also named VP70, F0 or fusion protein) consists of two components: F1 (also named VPG48) and F2 (also named VGP26) held together by disulphide bonds. The reported molecular weight of the VGP26 component varies between 20 to 26 kd.

Contributors

Inventor Institute
Ayham Alnabulsi Vertebrate Antibodies Limited
Cat. #: 151853
Unit size: 100 ug
Research Fields: Microbiology
Application: ELISA ; IF ; Fn ; WB
Target: Human Respiratory Syncytial (RS) virus Fusion protein.
Reactivity: Virus
Clone: 11-3-A3
Host: Mouse
Class: Monoclonal
Alternate name: VGP48, VGP7
Product description: Human Respiratory Syncytial Virus (RSV) is a major cause of lower respiratory tract illness and is the chief cause of hospitalization for respiratory tract illness in young children.The glycoprotein F is located on the surface of viral envelope, its function is to induce fusion of viral envelope with host-cell envelope resulting in syncytium formation. The glycoprotein F (also named VP70, F0 or fusion protein) consists of two components: F1 (also named VPG48) and F2 (also named VGP26) held together by disulphide bonds. The reported molecular weight of the VGP26 component varies between 20 to 26 kd.
Conjugation: Unconjugated
Isotype: IgG1 kappa
Immunogen: Gradient-purified RSF-44 virus (subgroup A) UV inactivated for 20 minutes at 20C
Myeloma used: P3X63Ag8
Target background: Human Respiratory Syncytial Virus (RSV) is a major cause of lower respiratory tract illness and is the chief cause of hospitalization for respiratory tract illness in young children.The glycoprotein F is located on the surface of viral envelope, its function is to induce fusion of viral envelope with host-cell envelope resulting in syncytium formation. The glycoprotein F (also named VP70, F0 or fusion protein) consists of two components: F1 (also named VPG48) and F2 (also named VGP26) held together by disulphide bonds. The reported molecular weight of the VGP26 component varies between 20 to 26 kd.
Format: Liquid
Concentration: 0.9-1.1mg/ml
Storage buffer: Dulbecco’s media containing 20% Fetal Bovine serum (DH20) prepared as follows (for final volume of 300ml: 237ml DMEM plus 60 ml Fetal Bovine Serum plus 3ml L-Glutamine).
Storage conditions: -15° C to -25° C
Shipping conditions: Dry ice
References:

Gimenez et al. 1986. Journal General Virology. 67: 863-70. PMID: 3517224 Gimenez et al. 1984. Journal General Virology. 65: 963-71. PMID: 6202832 Gimenez et al. 1987. Journal General Virology. 68: 1267-75. PMID: 3572364 Gimenez et al. 1996. Clinical and Diagnostic Laboratory Immunology, 3: 280-286, PMID: 8705669

Images

View Gallery

Related Tools for Antibodies

Cat. # Tool Name
151019 Anti-Mos [S3.1] Key Info View Tool
151021 Anti-CyclinB1 [V152] Key Info View Tool
151022 Anti-IL12 [1-1A4] Key Info View Tool
151027 Anti-HSVICP8 [10A3] Key Info View Tool
151017 Anti-MBP [R29.6] Key Info View Tool

Tool enquiry

Please ensure you use your organisation email address rather than personal where possible, as this helps us locate your organisation in our system faster.

Please note we may take up to three days to respond to your enquiry.

CancerTools.org uses the contact information provided to respond to you about our research tools and service. For more information please review our privacy policy.